TY - JOUR
T1 - Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve
T2 - A report of three cases
AU - Güner, Ahmet
AU - Bayam, Emrah
AU - Kalkan, Semih
AU - Gündüz, Sabahattin
AU - Özkan, Mehmet
N1 - Publisher Copyright:
© 2019 Turkish Society of Cardiology.
PY - 2019/1
Y1 - 2019/1
N2 - Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.
AB - Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.
KW - Low molecular weight heparin
KW - Mechanical heart valve
KW - Prosthetic valve thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85059797058&partnerID=8YFLogxK
U2 - 10.5543/tkda.2018.83364
DO - 10.5543/tkda.2018.83364
M3 - Article
C2 - 30628904
AN - SCOPUS:85059797058
SN - 1016-5169
VL - 47
SP - 63
EP - 68
JO - Turk Kardiyoloji Dernegi Arsivi
JF - Turk Kardiyoloji Dernegi Arsivi
IS - 1
ER -